NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
25 hedge funds and large institutions have $2.4M invested in InVivo Therapeutics Holdings Corp in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
25
Holders Change
+9
Holders Change %
+56.25%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$1.08M |
| 2 |
2
Renaissance Technologies
New York
|
$413K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$287K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$185K |
| 5 |
VF
5
Virtu Financial
New York
|
$139K |
Top Sellers
| 1 |
1
Two Sigma Advisers
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
26
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
EVM
27
Eaton Vance Management
Boston,
Massachusetts
| $0 | 49 | +49 | New |
|
28
Wells Fargo
San Francisco,
California
| $0 | 224 | +84 | +60% |
|